As of 2026-03-17, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (37.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -198.2%.
The range of the Relative Valuation is (35.48) - (37.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 25.6x | 23.4x |
| Forward P/E multiples | 21.6x - 23.0x | 22.3x |
| Fair Price | (35.48) - (37.78) | (37.53) |
| Upside | -192.8% - -198.9% | -198.2% |
| Date | P/E |